Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Colorcon
Medtronic
Moodys
McKinsey

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

DESOXIMETASONE - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for desoximetasone and what is the scope of patent protection?

Desoximetasone is the generic ingredient in three branded drugs marketed by Actavis Mid Atlantic, Akorn, Anda Repository, Fougera Pharms, Lupin Atlantis, Perrigo New York, Zydus Pharms, Taro Pharm Inds Ltd, Acp Nimble, Altana, Glenmark Generics, Novel Labs Inc, Perrigo Israel, Teligent Pharma Inc, and Taro Pharms, and is included in thirty-nine NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Desoximetasone has four patent family members in four countries.

There are seven drug master file entries for desoximetasone. Sixteen suppliers are listed for this compound.

Drug Prices for DESOXIMETASONE

See drug prices for DESOXIMETASONE

Drug Sales Revenue Trends for DESOXIMETASONE

See drug sales revenues for DESOXIMETASONE

Recent Clinical Trials for DESOXIMETASONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wake Forest University Health SciencesPhase 4
Siriraj clinical research centerPhase 3
SPS MEDICAL CO.,LTD.Phase 3

See all DESOXIMETASONE clinical trials

Recent Litigation for DESOXIMETASONE

Identify potential future generic entrants

District Court Litigation
Case NameDate
TARO PHARMACEUTICALS U.S.A., INC. v. GLENMARK PHARMACEUTICALS LTD.2018-08-08
Taro Pharmaceuticals U.S.A., Inc. v. Perrigo UK FINCO Limited Partnership2015-09-22

See all DESOXIMETASONE litigation

Pharmacology for DESOXIMETASONE
Medical Subject Heading (MeSH) Categories for DESOXIMETASONE
Synonyms for DESOXIMETASONE
(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
(1R,2S,10S,11S,13R,14S,15S,17S)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-dien-5-one
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one
17-Deoxymethansone
17-Desoximethasone
382-67-2
382D672
4E07GXB7AU
9-Fluoro-11-beta,21-dihydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione
9alpha-fluoro-11beta,21-dihydroxy-16alpha-methyl-1.4-pregnadiene-3,20-dione
9alpha-fluoro-16alpha-methyl-Delta(1)-corticosterone
A 41-304
A 41304
A-41-304
AB2000738
AC1NSJXQ
AKOS030254657
AS-15787
BDBM50103622
BRN 2228097
C-55186
CAS-382-67-2
CCG-101120
CHEBI:691037
CHEMBL1766
CS-3002
CTK8F9086
D03697
DB00547
Deoxymethasone
Desossimetasone
Desossimetasone [DCIT]
Desoximetason
Desoximetasona
Desoximetasona [INN-Spanish]
Desoximetasone (USP/INN)
Desoximetasone [USAN:USP:INN:BAN]
Desoximetasone pound>>A 41-304 pound>>17-deoxy Dexamethasone pound>>HOE 304
Desoximetasonum
Desoximetasonum [INN-Latin]
Desoxymethasone
Dexamethasone Impurity F
DSSTox_CID_25647
DSSTox_GSID_45647
DSSTox_RID_81025
DTXSID3045647
EINECS 206-845-3
Esperson
Flubason
GTPL7067
HMS2052C15
HMS2236H07
HOE 304
HOE-304
HY-17570
Ibaril
MLS000028654
MLS001076073
MLS001424230
MolPort-003-941-111
NC00370
NCGC00023648-03
NCGC00023648-04
Opera_ID_52
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-, (11beta,16alpha)-
Q-200938
Q790
R 2113
R-2113
SC-46986
SCHEMBL4214
SMR000058856
Stiedex
Topicort
Topicort (TN)
Topicort LP
Topisolon
Tox21_110889
Tox21_110889_1
UNII-4E07GXB7AU
VWVSBHGCDBMOOT-IIEHVVJPSA-N
ZINC4212854
Paragraph IV (Patent) Challenges for DESOXIMETASONE
Tradename Dosage Ingredient NDA Submissiondate
TOPICORT SPRAY;TOPICAL desoximetasone 204141 2013-12-18

US Patents and Regulatory Information for DESOXIMETASONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 078657-001 Sep 28, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Taro Pharms TOPICORT desoximetasone SPRAY;TOPICAL 204141-001 Apr 11, 2013 AT RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Actavis Mid Atlantic DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 204965-001 Nov 7, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Moodys
McKesson
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.